-
Mashup Score: 5Three osteoporosis risk assessment tools underperform in younger postmenopausal women - 5 day(s) ago
Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a study published in JAMA Network Open. Researchers assessed the performance of the Osteoporosis Self-Assessment Tool, the Osteoporosis Risk Assessment Instrument and the Osteoporosis Index of Risk, which are three of the five clinical risk
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1Clinical Update Conference | ADA - 5 day(s) ago
Updates related to the ADA Clinical Update Conference
Source: professional.diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
SAVE THE DATE! Stay at the forefront of diabetes care with our 2025 Clinical Update Conference https://t.co/XjSKh051HW https://t.co/UYjNMF3Tqc
-
-
Mashup Score: 0American Diabetes Association Statement on Canceled National Diabetes Prevention Program Funding | American Diabetes Association - 5 day(s) ago
The American Diabetes Association® (ADA) is extremely concerned about the impact of canceled National Institutes of Health funding on the success of the National Diabetes Prevention Program (National DPP), which was established to support people at risk of type 2 diabetes.Â
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
The ADA is deeply concerned about the cancellation of NIH funding for the National Diabetes Prevention Program’s long-term study—putting decades of progress at risk. We’re engaging w/congressional leaders & the administration to push for continued support. https://t.co/xWTLzPysmT https://t.co/CDoJX6tVqc
-
-
Mashup Score: 2
SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.
Source: www.endocrinologyadvisor.comCategories: General Medicine News, EndocrinologyTweet-
Preoperative #SGLT2Inhibitor use was not associated with an increased risk for postoperative #DiabeticKetoacidosis among patients with #T2D. https://t.co/FfBPhA8UxB
-
-
Mashup Score: 9Registration & Housing - 5 day(s) ago
Register to participate in ENDO 2025
Source: www.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
ENDO 2025 Member Registration Is Now Open | With over 7,000 attendees, nearly 2,500 abstracts and over 200 educational sessions, ENDO is the leading global meeting on endocrinology research and clinical care. Members can reserve their space: https://t.co/YGkTREi9gg #ENDO2025… https://t.co/JUionILruJ https://t.co/j1Duif9nUn
-
-
Mashup Score: 1Become an Advocate | ADA - 5 day(s) ago
Sign up today! Become an Diabetes advocate, use your voice to help people with diabetes thrive.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
Thank you @repglennivey, @ladyBspeaks & everyone who joined our DC Town Hall at @aboutKP. Local events ensure the ADA meets people where they are at. When we listen, we can advocate for change and prevent barriers to care. Join us! Become an advocate at: https://t.co/sDGptARbBO. https://t.co/e1LtaQTUkW
-
-
Mashup Score: 1
Digital health interventions were associated with small positive effects on anthropometric measures among children with obesity.
Source: www.endocrinologyadvisor.comCategories: General Medicine News, EndocrinologyTweet-
#DigitalHealth interventions elicited positive yet small effects on anthropometric indices in treatment for #PediatricObesity. https://t.co/7Z8WYzmM4D
-
-
Mashup Score: 6
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer new possibilities for long-term weight management, according to a recent review article published in Endocrinology. Authors Lauren A. Jones and Daniel I. Brierley, PhD, both of the Centre for Cardiovascular…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
A review article from @TheEndoSociety's Endocrinology journal explores how GLP-1RAs can further transform #obesity care and offer new possibilities for long-term weight management https://t.co/CRvTl4ty5c https://t.co/fYe7fxWOmu
-
-
Mashup Score: 2
This 45-minute webinar will bring together medical and regulatory experts to discuss the implications of compounded obesity drugs, including potential risks, regulatory challenges, and patient safety concerns.
Source: us02web.zoom.usCategories: General Medicine News, EndocrinologyTweet-
Join us on March 19 for a webinar discussing the implications of compounded obesity drugs compared to FDA-approved medications. Dr. Marc Andre-Cornier, Dr. Angela Fitch, and other experts will share perspectives. Register here: https://t.co/TGQ0hPKt4J https://t.co/UtwSoS7Tez
-
-
Mashup Score: 0Infographics | American Diabetes Association - 6 day(s) ago
Our infographics cover essential topics in diabetes care, serving as visual aids to simplifying complex concepts into actionable insights. We’re committed to empower you and the people you see to ensure optimal health and wellbeing. We offer both clinical and patient options you can access in our Patient Education Library. Download them now to have these invaluable resources readily accessible whenever you need them. What is recommended for diagnosing type 1 diabetes? Misdiagnosis of type 1 diabetes is
Source: professional.diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
Explore our latest infographics on: Understanding Diabetic Ketoacidosis (DKA): Learn symptoms, prevention, and critical management steps & Type 1 Diabetes Glycemic Management: Set effective goals and reduce risks of complications. 📲 https://t.co/kIU30QcPD3 https://t.co/VbJcQCQOGS
-
🚨Three risk assessment tools recommended by USPSTF for #osteoporosis screening had AUCs that were less than "acceptable" for women aged 50 to 64 years, researchers reported in @JAMANetworkOpen. @dgsomucla @UCLAMII @healiowomen @OrthoToday https://t.co/H4w0xUCIe6